Stephen Liu, MD, Georgetown Lombardi Comprehensive Cancer Center

Multidisciplinary Management of Patients With Stage III NSCLC

July 13th 2020

Integrating Perioperative Immunotherapy Strategies in NSCLC

July 13th 2020

Molecular testing in Patients With Metastatic NSCLC

July 13th 2020

ADAURA: Osimertinib as Adjuvant Therapy in Stage III EGFR+ NSCLC

July 13th 2020

Varied Timing of IO Therapy in Patients With Stage III NSCLC

July 13th 2020

Treating for Stage III NSCLC After Progression on Durvalumab

July 13th 2020

Durvalumab in Stage III NSCLC Based on Performance Status

July 13th 2020

PACIFIC Trial: Durvalumab Following Chemotherapy for Stage III NSCLC

July 13th 2020

Mediastinal Staging in Non–Small Cell Lung Cancer

July 13th 2020

Dr. Liu on the CheckMate-032 Trial in SCLC

December 17th 2019

Stephen Liu, MD, discusses the CheckMate-032 trial in small cell lung cancer.

Dr. Liu on NRG1 Fusions in Oncology

October 4th 2019

Stephen Liu, MD, associate professor of medicine, Division of Hematology and Oncology, Georgetown University Medical Center, discusses the prevalence of NRG1 fusions in oncology.

Dr. Liu on the Potential of Pembrolizumab in SCLC

May 8th 2019

Stephen Liu, MD, associate professor of medicine, Division of Hematology and Oncology, Georgetown University Medical Center, discusses the potential of pembrolizumab in the treatment of patients with small cell lung cancer.

Dr. Liu on Navigating the Frontline Treatment of ALK+ NSCLC

November 9th 2018

Stephen Liu, MD, associate professor of medicine, Division of Hematology and Oncology, Georgetown University Medical Center, discusses the frontline treatment of ALK-positive non–small cell lung cancer (NSCLC).

Dr. Liu on Sequencing Therapy in ALK-Positive NSCLC

October 2nd 2018

Stephen Liu, MD, associate professor of medicine, Division of Hematology and Oncology, Georgetown University Medical Center, discusses sequencing strategies for patients with ALK-positive non–small cell lung cancer (NSCLC).

Dr. Liu on Resistance Mechanisms in EGFR-Mutant Lung Cancer

August 14th 2018

Stephen Liu, MD, associate professor of medicine, Division of Hematology and Oncology, Georgetown University Medical Center, discusses resistance mechanisms in EGFR-mutant lung cancer.

Dr. Liu on Potentially Promising Combinations in ALK-Positive NSCLC

July 7th 2018

Stephen Liu, MD, associate professor of medicine, Division of Hematology and Oncology, Georgetown University Medical Center, discusses potentially promising combinations in ALK-positive non–small cell lung cancer (NSCLC).

Dr. Liu on ALK-Targeted Agents in NSCLC

July 3rd 2018

Stephen Liu, MD, associate professor of medicine, Division of Hematology and Oncology, Georgetown University Medical Center, discusses ALK-targeted agents in the field of non–small cell lung cancer (NSCLC).